Would A Mortality Endpoint Be The Death Knell For Antibiotics Development?

FDA's Anti-Infective Drugs Advisory Committee meets Dec. 9 to discuss trial designs for community-acquired pneumonia, but a leading expert sees that as a step backward.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet